Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Pierre Sié"'
Autor:
John Rendu, Claire Flaujac, Julien Fauré, Marie-Pierre Gratacap, Pierre Sié, Pascale Gaussem, Christilla Bachelot-Loza, Geneviève Baujat, Aurore Marchelli, Rémi Salomon, Marion Egot, Dominique Pidard, Sonia Poirault-Chassac, Sophie Gandrille, Elise Dreano, Tristan Mirault, Dominique Baruch, Dominique Lasne, Caroline Elie
Publikováno v:
British journal of haematologyReferences. 192(5)
Lowe syndrome (LS) is an oculocerebrorenal syndrome of Lowe (OCRL1) genetic disorder resulting in a defect of the OCRL protein, a phosphatidylinositol-4,5-bisphosphate 5-phosphatase containing various domains including a Rho GTPase-activating protein
Autor:
Pierre Souleyreau, Juliane M. Jürgensmeier, Cédric Garcia, Loic Ysebaert, Pierre Sié, Agnès Ribes, Bernard Payrastre, Jennifer Series, Anne Bauters, Franck Morschhauser
Publikováno v:
Journal of thrombosis and haemostasis : JTHREFERENCES. 18(12)
Background Inhibitors of tyrosine kinases downstream of the B-cell receptor, such as Bruton's tyrosine kinase (Btk) or Spleen tyrosine kinase (Syk), used alone or in combination are new therapeutic options in the treatment of B-cell malignancies. A c
Publikováno v:
Hématologie. 22:276-283
Les pathologies plaquettaires constitutionnelles (thrombopenies, thrombopathies ou association des deux) forment un ensemble tres heterogene de maladies rares dont le risque hemorragique spontane est variable, mais qui sont souvent revelees par un sa
Autor:
Marie Levade, Elodie David, Pierre-Alexandre Laurent, Loic Ysebaert, Anne-Sophie Michallet, Constantine S. Tam, Sarah Cadot, Cédric Garcia, Pierre Sié, Jean-Claude Bordet, Bernard Payrastre
Publikováno v:
Blood. 124:3991-3995
The oral Bruton's tyrosine kinase inhibitor, ibrutinib, has recently demonstrated high efficiency in patients with relapsed B-cell malignancies. Occurrence of bleeding events has been reported in a subgroup of ibrutinib-treated patients. We demonstra
Publikováno v:
Platelets in Thrombotic and Non-Thrombotic Disorders ISBN: 9783319474601
Discovered in the 1980s, the procoagulant function of platelets is due to their inherent ability to provide, following activation, a critical platform at their plasma membrane surface for the activation of blood clotting enzyme complexes to generate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a20f705b820fb8d2d0baaabdce2f9cf6
https://doi.org/10.1007/978-3-319-47462-5_63
https://doi.org/10.1007/978-3-319-47462-5_63
Autor:
Sonia Severin, C. Broccardo, Cédric Garcia, Pierre Sié, Bernard Payrastre, P. Couvert, P. Le Faouder, Béatrice Hechler, Justine Bertrand-Michel, G. Chimini, J. Van Rothem, T. Lhermusier
Publikováno v:
Journal of Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis, Wiley, 2016, 14 (3), pp.585-595. ⟨10.1111/jth.13247⟩
Journal of Thrombosis and Haemostasis, 2016, 14 (3), pp.585-595. ⟨10.1111/jth.13247⟩
Journal of Thrombosis and Haemostasis, Wiley, 2016, 14 (3), pp.585-595. ⟨10.1111/jth.13247⟩
Journal of Thrombosis and Haemostasis, 2016, 14 (3), pp.585-595. ⟨10.1111/jth.13247⟩
International audience; The role of ATP-binding cassette transporter 1 (ABCA1) in platelet functions is poorly characterized. We studied the impact of ABCA1 deficiency on platelet responses in a mouse model and two Tangier patients. ABCA1-deficient p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dc0d0561f5005d8cd072c5578bf6123
https://hal.archives-ouvertes.fr/hal-01438524
https://hal.archives-ouvertes.fr/hal-01438524
Autor:
Jean-François Arnal, Cendrine Cabou, Pierre Sié, Marie-Cécile Valéra, Pierre Gourdy, Françoise Lenfant, Bernard Payrastre, Nathalie Laurent, Marlène Marcellin, Michel Sixou, Marie-Pierre Gratacap, Céline E. Toutain
Publikováno v:
Blood
Blood, 2012, 120 (8), pp.1703-12. ⟨10.1182/blood-2012-01-405498⟩
Blood, American Society of Hematology, 2012, 120 (8), pp.1703-12. ⟨10.1182/blood-2012-01-405498⟩
Blood, 2012, 120 (8), pp.1703-12. ⟨10.1182/blood-2012-01-405498⟩
Blood, American Society of Hematology, 2012, 120 (8), pp.1703-12. ⟨10.1182/blood-2012-01-405498⟩
Although estrogens are known to have a deleterious effect on the venous thrombosis risk and a preventive action on the development of arterial atheroma, their effect on platelet function in vivo remains unclear. Here, we demonstrate that a chronic hi
Publikováno v:
Journal of Oral Pathology & Medicine. 42:115-124
J Oral Pathol Med (2013)42: 115–124 Platelets play a key role in thrombosis and hemostasis. Accumulation of platelets at the site of vascular injury is the first step in the formation of hemostatic plugs, which play a pivotal role in preventing blo
Autor:
Bernard Payrastre, Thibault Lhermusier, Pierre Sié, Valérie Martin, J. Van Rottem, Marie-Pierre Gratacap, Ashraf Ragab, Cédric Garcia, Jean-Marie Xuereb
Publikováno v:
Journal of Thrombosis and Haemostasis. 9:2067-2076
Background Heparin-induced thrombocytopenia (HIT) is a rare but severe complication of heparin therapy in which immunoglobulin G (IgG) antibodies against the platelet factor 4-heparin complex activate platelets through the FcγRIIA receptor. Clusteri
Autor:
J. M. Xuereb, Anne-Dominique Terrisse, Pierre Gourdy, Bernard Payrastre, N. Puech, Sophie Allart, Pierre Sié
Publikováno v:
Journal of Thrombosis and Haemostasis. 8:2810-2819
Summary. Background: Microparticles (MPs) released by activated or apoptotic cells increase in number in the blood of subjects with vascular or metabolic diseases and may contribute to thrombotic complications. Objectives: In this study, we investiga